| Literature DB >> 17608944 |
Brian Bullard1, Serena Lipski, Eric R Lafontaine.
Abstract
BACKGROUND: The Moraxella catarrhalis Hag protein, an Oca autotransporter adhesin, has previously been shown to be important for adherence of this respiratory tract pathogen to human middle ear and A549 lung cells.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17608944 PMCID: PMC1931440 DOI: 10.1186/1471-2180-7-65
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Adherence of . Black bars correspond to WT isolates and hag isogenic mutant strains are represented by open bars. The results are expressed as the mean (± standard error) percentage of inoculated bacteria binding to monolayers. The number above each bar represents mean percentage; standard error is shown in parentheses. Asterisks indicate that the difference in adherence between a WT strain and its respective hag mutant is statistically significant.
Figure 2Adherence of recombinant . Panels A and B: Adherence is expressed as the mean percentage (± standard error) of inoculated bacteria binding to monolayers. Panel C: Adherence is expressed as the normalized mean number of bacteria per microscopic fields (± standard error) binding to collagen type IV coated wells. The number above each bar represents the mean; standard error is shown in parentheses. Asterisks indicate that the difference in binding between E. coli expressing O35E-Hag (i.e. pELO35.Hag), O12E-Hag (i.e. pBBO12.Hag) or V1171-Hag (i.e. pSV1171.Hag) and the negative control is statistically significant.
Figure 3Selected structural features of O35E-Hag, schematic representation of in-frame deletions introduced in the protein, and adherence of recombinant . Selected structural features are shown above in relation to their physical location within the O35E-Hag protein. Deletions within the protein are represented by gaps. Construct names are shown to the left. The columns to the right of each construct indicate the binding of E. coli expressing the mutated protein to NCIH292 cells (N), HMEE (H) or collagen (C). Adherence to NCIH292 and HMEE cells is expressed as the mean percentage (standard error shown in parentheses) of inoculated bacteria binding to monolayers. Adherence to collagen is expressed as the normalized mean number of bacteria per microscopic fields (standard error shown in parentheses) binding to collagen type IV coated wells; we estimated that 20 to 35 bacteria per microscopic field corresponds to 5–15% of input bacteria. Asterisks indicate that the difference in binding between E. coli expressing Hag proteins and the negative control is statistically significant. The negative control corresponds to E. coli carrying the plasmid control pCC1.3 and WT corresponds to recombinant bacteria harboring plasmid pELO35.Hag. The rectangles at the bottom indicate regions important for adherence to epithelial cells and collagen.
Figure 4Western blot analysis of Sarkosyl-insoluble OM proteins extracted from . OM preparations were obtained from E. coli carrying the plasmids pCC1.3 (lane 1), pELO35.Hag (lane 2), pBBHS2.24 (lane 3), pBBHS3.20 (lane 4), pBBHS8.18 (lane 5), pBBHS6.22 (lane 6), pBBHS5.12 (lane 7), pBBHS10.9 (lane 8) and pBBHS10.32 (lane 9). These preparations were resolved by SDS-PAGE, transferred to PVDF membranes and probed with antibodies against the purified recombinant protein His.Hag.CT. The figure is a composite of several western blot experiments in which OM preparations of the negative control (i.e. pCC1.3) and the positive control (i.e. pELO35.Hag) were included. Molecular weight markers are shown to the left in kDa. The numbers at the bottom of the western panel represent the predicted molecular weight of each Hag protein.
Figure 5Western blot analysis of recombinant . E. coli carrying the plasmids pELO35.Hag (lanes 1 and 2), pBBHS2.24 (lanes 3 and 4) and pBBHS3.20 (lanes 5 and 6) were incubated for 15 min on ice in the presence (lanes 2, 4 and 6) or absence (lanes 1, 3 and 5) of proteinase K. These cells were lysed, resolved by SDS-PAGE, transferred to PVDF membranes and probed with the anti-Hag antibody 5D2 (panel A) or anti-TonB antibody 4F1 (panel B). Molecular weight markers are shown to the left in kDa.
Strains and plasmids
| [26] | ||
| O35E | Wild-type isolate | [26] |
| O35E.TN2 | Isogenic | [26] |
| O12E | Wild-type isolate | [26] |
| O12E.Hag | Isogenic | [26] |
| TTA37 | Wild-type isolate | [26] |
| TTA37.Hag | Isogenic | [26] |
| V1171 | Wild-type isolate | [26] |
| V1171.Hag | Isogenic | [26] |
| McGHS1 | Wild-type isolate | [26] |
| McGHS1.Hag | Isogenic | [26] |
| EPI300 | Cloning strain | Epicentre |
| TUNER | Expression strain | Novagen |
| Plasmids | ||
| pETcoco-1 | Protein expression vector, Cmr | Novagen |
| pBBCT.77 | pETcoco-1 expressing O35E-Hag aa 1358–1964 joined to six N-terminal histidine residues, Cmr | This study |
| pCC1.3 | Adherence negative plasmid control | [48] |
| pCC1 | Cloning vector, Cmr | Epicentre |
| pELO35.Hag | pCC1 expressing the entire O35E | [26] |
| pBBO12.Hag | pCC1 expressing the entire O12E | [26] |
| pSV1171.Hag | pCC1 expressing the entire V1171 | [26] |
| pBBHS2.24 | Deletion derivative of pELO35.Hag, missing aa 71–283 | This study |
| pBBHS3.20 | Deletion derivative of pELO35.Hag, missing aa 71–384 | This study |
| pBBHS8.18 | Deletion derivative of pELO35.Hag, missing aa 71–384 and 1546–1707 | This study |
| pBBHS6.22 | Deletion derivative of pELO35.Hag, missing aa 436–1538 | This study |
| pBBHS5.12 | Deletion derivative of pELO35.Hag, missing aa 71–283 and 919–1538 | This study |
| pBBHS10.9 | Deletion derivative of pELO35.Hag, missing aa 71–384, 746–1193 and 1546–1707 | This study |
| pBBHS10.32 | Deletion derivative of pELO35.Hag, missing aa 71–705 and 1546–1707 | This study |